drug
as of 2026-07-01CVL-562 (PF-06412562) 15 mg
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Yale University
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
1
A Translational and Neurocomputational Evaluation of a Dopamine Receptor 1 Partial Agonist for Schizophrenia
NCT04457310Phase 2Completed
KOLs & investigators
1
John Krystal, MDKOL score 8
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here